General
Minapharm Pharmaceuticals (MIPH.CA) - Listing Committee Decision
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
With reference to the provisions of Article 46 of the Listing Rules, related to preparing and providing the EGX with the consolidated financial statements for the financial year ending on 31/12/2025 the Listing Committee held on 06/05/2026 decided to impose an EGP 5000 penalty on the company. Grant the company a period of 15 days from the end of the granted period to provide EGX with the consolidated financial statements for the financial year ending on 31/12/2025 in light of the provisions of Article 64 of the executive regulations.
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
With reference to the provisions of Article 46 of the Listing Rules, related to preparing and providing the EGX with the consolidated financial statements for the financial year ending on 31/12/2025 the Listing Committee held on 06/05/2026 decided to impose an EGP 5000 penalty on the company. Grant the company a period of 15 days from the end of the granted period to provide EGX with the consolidated financial statements for the financial year ending on 31/12/2025 in light of the provisions of Article 64 of the executive regulations.